New generation of peptide antibiotics

The increasing antibiotic resistance of pathogenic bacteria calls for the development of alternative antimicrobial strategies. Possible approaches include the development of novel, broad-spectrum antibiotics as well as specific targeting of individual bacterial virulence factors. It is impossible to decide currently which strategy will prove more successful in the future since they both promise different advantages, but also introduce diverse problems. Considering both approaches, our laboratory's research focuses on the evaluation of hemocidins, broad-spectrum antibacterial peptides derived from hemoglobin and myoglobin, and staphostatins, specific inhibitors of staphopains -- Staphylococcus aureus secreted proteases that are virulence factors regarded as possible targets for therapy. The article summarizes recent advances in both fields of study and presents perspectives for further development and possible applications.     

New insect system for testing antibiotics

New and efficient methods to screen antibiotics are needed to counter increased antibiotic resistance in pathogens and the emergence of new diseases. Here we report a new insect model for screening antibiotics in vivo using the grasshopper Romalea microptera. The system is inexpensive, efficient, and flexible, avoids animal-welfare problems, and can be used to test against most major pathogenic groups. We employed this system to test 11 commercial antibiotics against a pathogenic Encephalitozoon species (Microsporidia). Oral treatment with fumagillin or thiabendazole significantly reduced pathogen spore counts, whereas spore counts of grasshoppers fed with albendazole, ampicillin, chloramphenicol, griseofulvin, metronidazole, sulfadimethoxine, or tetracycline were not significantly different from the infected controls. Quinine produced a distinct, but nonsignificant, reduction in spores, and streptomycin a nonsignificant increase in spores. Although 2 antibiotics significantly reduced spore counts, in no case was the pathogen totally eliminated. This study demonstrates the validity of this system as a method to screen antibiotics. It also corroborates the difficulty researchers and physicians have had in treating microsporidia infections, and suggests that quinine and related alkaloid compounds should be further examined as possible therapeutic agents against this group of ubiquitous pathogens. In addition, streptomycin and related compounds should be tested to determine if this widely used antibiotic enhances microsporidiosis.     

New antibiotics from bacterial natural products

For the past five decades, the need for new antibiotics has been met largely by semisynthetic tailoring of natural product scaffolds discovered in the middle of the 20(th) century. More recently, however, advances in technology have sparked a resurgence in the discovery of natural product antibiotics from bacterial sources. In particular, efforts have refocused on finding new antibiotics from old sources (for example, streptomycetes) and new sources (for example, other actinomycetes, cyanobacteria and uncultured bacteria). This has resulted in several newly discovered antibiotics with unique scaffolds and/or novel mechanisms of action, with the potential to form a basis for new antibiotic classes addressing bacterial targets that are currently underexploited.     

Key biocultural values to guide restoration action and planning in New Zealand

A pluralist and cross‐cultural approach that accommodates differing values while encouraging the collaboration and social cohesion necessary for the complex task of ecological restoration is needed. We used qualitative and quantitative analyses to investigate value assigned to biocultural restoration of coastal forests in northern New Zealand by 26 interviewees from three groups (environmental managers, Māori community members, and community project leaders). Māori community members primarily emphasized the importance of Cultural Stewardship and Use in the restoration process, while placing less emphasis on Ecological Integrity. Otherwise, all participants shared common trends, culminating in three interrelated value sets: (1) Personal Engagement, (2) Connection, and (3) the generation and transfer of Knowledge & Wisdom. These values demonstrate that restoration's benefits to people and community are as significant as its reparations of ecological components. Despite differences, all stakeholders were united in a broadly common goal to restore socio‐ecological systems. Their knowledge and shared passion for conservation signal enormous promise for accelerated and effective restoration of coastal forests, if it is conducted using a pluralistic approach. Because some values expressed were intangible and complex, with cross‐cultural dimensions, current valuation tools used by ecological economists to guide management investment fail to adequately account for, in particular, Māori values of ecological restoration.     

New methods of biosynthetic production of antibiotics

Исследовалось влияние некоторых антибиотиков, продуцируемых актиномицетами, на биосинтез стрентомицина, хлортетрациклина, окситетрациклина, эритромицина и фунгицидина. Было установлено, что фунгицидин лишь весьма незначительно понижает продукцию стрептомицина, хлортетрациклина и окситетрациклина и что хлортетрациклин и окситетрациклин сравнительно мало понижают продукцию фунгицидина. На основании этих данных был успешно проведен биосинтез фунгицидина без соблюдения условий асептики, причем в кччестве защитного средства культуры штамма-продуцента от заражения чужеродной микрофлорой при ферментации применялся окситетрациклин в концентрации 50 мкб/мл ферментационнойсреды. Фунгицидин оправдал себя для защиты от заражения грибками при производстве технического хлортетрациклина путем культивации штамма продуцента на янмене грубого помола.     

New antibiotics produced by Bacillus subtilis strains

Two Bacillus subtilis strains isolated from the fruiting body of a basidiomycete fungus Pholiota squarrosa exhibited a broad range of antibacterial activity, including those against methicillin-resistant Staphylococcus aureus INA 00761 (MRSA) and Leuconostoc mesenteroides VKPM B-4177 resistant to glycopeptide antibiotics, as well as antifungal activity. The strains were identified as belonging to the “B. subtilis” complex based on their morphological and physiological characteristics, as well as by sequencing the 16S rRNA gene fragments. Both strains (INA 01085 and INA 01086) produced insignificant amounts of polyene antibiotics (hexaene and pentaene, respectively). Strain INA 01086 also produced a cyclic polypeptide antibiotic containing Asp, Gly, Leu, Pro, Tyr, Thr, Trp, and Phe, while the antibiotic of strain INA 01085 contained, apart from these, two unidentified nonproteinaceous amino acids. Both polypeptide antibiotics were new compounds efficient against gram-positive bacteria and able to override the natural bacterial antibiotic resistance.